Real-world data of 12-month adjunct sodium-glucose co-transporter-2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: Improved HbA1c without diabetic ketoacidosis.
Jochen SeufertStefanie LanzingerThomas DannePeter BramlageSebastian M SchmidFlorian KoppStephan KressPeter FaschingClaus SchäferReinhard W Hollnull nullPublished in: Diabetes, obesity & metabolism (2021)